CoChat

Thioredoxin interacting protein (TXNIP) regulates tubular autophagy and mitophagy in diabetic nephropathy through the mTOR signaling pathway

Open access

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Hyperglycemia upregulates thioredoxin interacting protein (TXNIP) expression, which in turn induces ROS production, inflammatory and fibrotic responses in the diabetic kidney. Dysregulation of autophagy contributes to the development of diabetic nephropathy. However, the interaction of TXNIP with autophagy/mitophagy in diabetic nephropathy is unknown. In this study, streptozotocin-induced diabetic rats were given TXNIP DNAzyme or scrambled DNAzyme for 12 weeks respectively. Fibrotic markers, mitochondrial function and mitochondrial reactive oxygen species (mtROS) were assessed in kidneys. Tubular autophagy and mitophagy were determined in kidneys from both human and rats with diabetic nephropathy. TXNIP and autophagic signaling molecules were examined. TXNIP DNAzyme dramatically attenuated extracellular matrix deposition in the diabetic kidneys compared to the control DNAzyme. Accumulation of autophagosomes and reduced autophagic clearance were shown in tubular cells of human diabetic compared to non-diabetic kidneys, which was reversed by TXNIP DNAzyme. High glucose induced mitochondrial dysfunction and mtROS production and inhibited mitophagy in proximal tubular cells, which was reversed by TXNIP siRNA. TXNIP inhibition suppressed diabetes-induced BNIP3 expression and activation of the mTOR signaling pathway. Collectively, hyperglycemia-induced TXNIP contributes to the dysregulation of tubular autophagy and mitophagy in diabetic nephropathy through activation of the mTOR signaling pathway.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep29196

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Inhibition of TXNIP attenuated diabetic-induce renal interstitial collagen deposition and overexpression of type I collagen in diabetic rats. (mRen-2) 27 rats were injected with streptozotocin (STZ) to induce diabetes or citrate buffer alone as non-diabetic control. Kidney tissues were collected for immnostaining at 12 weeks after the induction of diabetes. (a) Representative images show picrosirius red and immunohistochemical staining of type I collagen in the renal cortex from non-diabetic controls (non-DM control), diabetic rats treated with scrambled DNAzyme (DM + Scrambled DNAzyme) and diabetic rats treated with TXNIP DNAzyme (DM + TXNIP DNAzyme). N = 6. Quantitation of the degree of tubulointerstitial injury (b) and type I collagen (c). HK2 cells transfected with scrambled siRNA or TXNIP specific siRNA were treated with high glucose for 48 hours. (d) Western blot analysis showed that TXNIP siRNA inhibited high glucose-induced type I collagen expression in HK2 cells. (e) Quantification of type I collagen expression in high glucose-induced HK2 cells. Results are presented as mean ± SEM. *P < 0.05 and **P < 0.01. N = 4. Original magnification: ×200.
Figure 1 Inhibition of TXNIP attenuated diabetic-induce renal interstitial collagen deposition and overexpression of type I collagen in diabetic rats. (mRen-2) 27 rats were injected with streptozotocin (STZ) to induce diabetes or citrate buffer alone as non-diabetic control. Kidney tissues were collected for immnostaining at 12 weeks after the induction of diabetes. (a) Representative images show picrosirius red and immunohistochemical staining of type I collagen in the renal cortex from non-diabetic controls (non-DM control), diabetic rats treated with scrambled DNAzyme (DM + Scrambled DNAzyme) and diabetic rats treated with TXNIP DNAzyme (DM + TXNIP DNAzyme). N = 6. Quantitation of the degree of tubulointerstitial injury (b) and type I collagen (c). HK2 cells transfected with scrambled siRNA or TXNIP specific siRNA were treated with high glucose for 48 hours. (d) Western blot analysis showed that TXNIP siRNA inhibited high glucose-induced type I collagen expression in HK2 cells. (e) Quantification of type I collagen expression in high glucose-induced HK2 cells. Results are presented as mean ± SEM. *P < 0.05 and **P < 0.01. N = 4. Original magnification: ×200.CC BY · PubMed Central
Figure 2 LC3 and P62 expression were increased in the renal tubular cells of the patients with diabetic nephropathy. Immunofluorescence staining showed increased expression of LC3 (a) and P62 (c) in kidney biopsies from the patients with diabetic nephropathy (DN) compared with the non-diabetic control kidneys (Non-DN control). Quantitation of LC3 (b) and P62 (d) expression in human biopsies. Results are presented as mean ± SEM. **P < 0.01. N = 6. Original magnification: ×600.
Figure 2 LC3 and P62 expression were increased in the renal tubular cells of the patients with diabetic nephropathy. Immunofluorescence staining showed increased expression of LC3 (a) and P62 (c) in kidney biopsies from the patients with diabetic nephropathy (DN) compared with the non-diabetic control kidneys (Non-DN control). Quantitation of LC3 (b) and P62 (d) expression in human biopsies. Results are presented as mean ± SEM. **P < 0.01. N = 6. Original magnification: ×600.CC BY · PubMed Central
Figure 3 Inhibition of TXNIP attenuated diabetes-induced upregulation of LC3 and P62 expression in the renal tubule cells of diabetic rats. (mRen-2) 27 rats were injected with STZ to induce diabetes or citrate buffer alone as non-diabetic control. Kidney tissues were collected for immnostaining at 12 weeks after the induction of diabetes. Immunofluorescence staining showed that TXNIP DNAzyme treatment attenuated diabetes-induced upregulation of LC3 (a) and P62 (c) expression in the renal tubule cells of diabetic rats. Quantification of LC3 (b) and P62 (d) expression in rat kidney tissues. Results are presented as mean ± SEM. *P < 0.05 and **P < 0.01. N = 6. Original magnification: ×600.
Figure 3 Inhibition of TXNIP attenuated diabetes-induced upregulation of LC3 and P62 expression in the renal tubule cells of diabetic rats. (mRen-2) 27 rats were injected with STZ to induce diabetes or citrate buffer alone as non-diabetic control. Kidney tissues were collected for immnostaining at 12 weeks after the induction of diabetes. Immunofluorescence staining showed that TXNIP DNAzyme treatment attenuated diabetes-induced upregulation of LC3 (a) and P62 (c) expression in the renal tubule cells of diabetic rats. Quantification of LC3 (b) and P62 (d) expression in rat kidney tissues. Results are presented as mean ± SEM. *P < 0.05 and **P < 0.01. N = 6. Original magnification: ×600.CC BY · PubMed Central
Figure 4 Inhibition of TXNIP reversed high glucose-induced mitochondrial dysfunction in HK2 cells. HK2 cells transfected with scrambled siRNA or TXNIP siRNA were treated with high glucose for 48 hours. (a) Mitochondrial function was assessed by ATP production rate. Treatment of HK2 cells with TXNIP siRNA significantly reversed high glucose-induced inhibition of mitochondrial ATP production rate. (b) Mitochondrial reactive oxygen species (mtROS) production was assessed by MitoSOX Red. Treatment of HK2 cells with TXNIP siRNA significantly reversed high glucose-induced mtROS production. (c) Quantification of MitoSOX Red fluorescence intensity in HK2 cells. Results are presented as mean ± SEM. **P < 0.01. N = 4. Original magnification: ×600.
Figure 4 Inhibition of TXNIP reversed high glucose-induced mitochondrial dysfunction in HK2 cells. HK2 cells transfected with scrambled siRNA or TXNIP siRNA were treated with high glucose for 48 hours. (a) Mitochondrial function was assessed by ATP production rate. Treatment of HK2 cells with TXNIP siRNA significantly reversed high glucose-induced inhibition of mitochondrial ATP production rate. (b) Mitochondrial reactive oxygen species (mtROS) production was assessed by MitoSOX Red. Treatment of HK2 cells with TXNIP siRNA significantly reversed high glucose-induced mtROS production. (c) Quantification of MitoSOX Red fluorescence intensity in HK2 cells. Results are presented as mean ± SEM. **P < 0.01. N = 4. Original magnification: ×600.CC BY · PubMed Central
Figure 5 TXNIP gene silencing reversed high glucose-induced inhibition of mitophagy. HK2 cells transfected with scrambled siRNA or TXNIP siRNA were treated with high glucose for 48 hours. (a) Transmission electron microscopy evaluation of mitophagy in high glucose-induced HK2 cells. Representative electron micrographs show mitochondria morphology in treated HK2 cells. Red arrow indicates well developed/preserved mitochondrial structures, while black arrows show abnormalities in mitochondria morphology indicative of mitophagy with dark electron dense mitochondria lacking typical cristae or residual mitochondrial bodies present in autolysosomes. Scale bars, 0.2 μm. Confocal microscopy of MitoTracker Red-labeled mitochondria and LC3 staining (b) and quantification of colocalization rate (c) and fluorescence intensity (d) of LC3/MitoTracker Deep Red. Confocal microscopy of MitoTracker Red-labeled mitochondria and P62 staining (e) and quantification of colocalization rate (f) and fluorescence intensity (g) of P62/MitoTracker Deep Red in HK2 cells. Results are presented as mean ± SEM. *P < 0.05 and **P < 0.01. N = 4. Original magnification: ×600.
Figure 5 TXNIP gene silencing reversed high glucose-induced inhibition of mitophagy. HK2 cells transfected with scrambled siRNA or TXNIP siRNA were treated with high glucose for 48 hours. (a) Transmission electron microscopy evaluation of mitophagy in high glucose-induced HK2 cells. Representative electron micrographs show mitochondria morphology in treated HK2 cells. Red arrow indicates well developed/preserved mitochondrial structures, while black arrows show abnormalities in mitochondria morphology indicative of mitophagy with dark electron dense mitochondria lacking typical cristae or residual mitochondrial bodies present in autolysosomes. Scale bars, 0.2 μm. Confocal microscopy of MitoTracker Red-labeled mitochondria and LC3 staining (b) and quantification of colocalization rate (c) and fluorescence intensity (d) of LC3/MitoTracker Deep Red. Confocal microscopy of MitoTracker Red-labeled mitochondria and P62 staining (e) and quantification of colocalization rate (f) and fluorescence intensity (g) of P62/MitoTracker Deep Red in HK2 cells. Results are presented as mean ± SEM. *P < 0.05 and **P < 0.01. N = 4. Original magnification: ×600.CC BY · PubMed Central
Figure 6 Inhibition of TXNIP suppressed diabetes-induced upregulation of BNIP3 expression in HK2 cells and the renal tubule cells of diabetic rats. HK2 cells transfected with scrambled siRNA or TXNIP specific siRNA were treated with high glucose for 48 hours. (a) Western blot analysis showed that TXNIP siRNA inhibited high glucose-induced BNIP3 expression in HK2 cells. (b) Quantification of BNIP3 in high glucose-induced HK2 cells. N = 4. (c) Representative images show immunohistochemical staining of BNIP3 in the renal cortex from non-DM control, diabetic rat treated with scrambled DNAzyme (DM + Scrambled DNAzyme) and diabetic rats treated with TXNIP DNAzyme (DM + TXNIP DNAzyme). N = 6. (d) Quantitation of BNIP3 expression in rat kidney tissues. Results are presented as mean ± SEM. **P < 0.01. Original magnification: ×200.
Figure 6 Inhibition of TXNIP suppressed diabetes-induced upregulation of BNIP3 expression in HK2 cells and the renal tubule cells of diabetic rats. HK2 cells transfected with scrambled siRNA or TXNIP specific siRNA were treated with high glucose for 48 hours. (a) Western blot analysis showed that TXNIP siRNA inhibited high glucose-induced BNIP3 expression in HK2 cells. (b) Quantification of BNIP3 in high glucose-induced HK2 cells. N = 4. (c) Representative images show immunohistochemical staining of BNIP3 in the renal cortex from non-DM control, diabetic rat treated with scrambled DNAzyme (DM + Scrambled DNAzyme) and diabetic rats treated with TXNIP DNAzyme (DM + TXNIP DNAzyme). N = 6. (d) Quantitation of BNIP3 expression in rat kidney tissues. Results are presented as mean ± SEM. **P < 0.01. Original magnification: ×200.CC BY · PubMed Central
Figure 7 Inhibition of TXNIP suppressed high glucose-induced activation of the mTOR signaling pathway. HK2 cells transfected with scrambled siRNA or TXNIP specific siRNA were treated with high glucose for 48 hours. Western blot analysis showed that TXNIP siRNA inhibited high glucose-induced phosphorylation of mTOR (a) and p70S6 (c) in HK2 cells. Quantification of phosphorylation of mTOR (b) and p70S6 (d) in the high glucose-treated HK2 cells. N = 4. (e) Representative images show immunohistochemical staining of phosphorylation of mTOR in the renal cortex from non-DM control, diabetic rats treated with scrambled DNAzyme (DM + Scrambled DNAzyme) and diabetic rats treated with TXNIP DNAzyme (DM + TXNIP DNAzyme). (f) Quantitation of phosphorylation of mTOR expression in rat kidney tissues. N = 6. Results are presented as mean ± SEM. *P < 0.05 and **P < 0.01. Original magnification: ×200.
Figure 7 Inhibition of TXNIP suppressed high glucose-induced activation of the mTOR signaling pathway. HK2 cells transfected with scrambled siRNA or TXNIP specific siRNA were treated with high glucose for 48 hours. Western blot analysis showed that TXNIP siRNA inhibited high glucose-induced phosphorylation of mTOR (a) and p70S6 (c) in HK2 cells. Quantification of phosphorylation of mTOR (b) and p70S6 (d) in the high glucose-treated HK2 cells. N = 4. (e) Representative images show immunohistochemical staining of phosphorylation of mTOR in the renal cortex from non-DM control, diabetic rats treated with scrambled DNAzyme (DM + Scrambled DNAzyme) and diabetic rats treated with TXNIP DNAzyme (DM + TXNIP DNAzyme). (f) Quantitation of phosphorylation of mTOR expression in rat kidney tissues. N = 6. Results are presented as mean ± SEM. *P < 0.05 and **P < 0.01. Original magnification: ×200.CC BY · PubMed Central
Figure 8 Inhibition of mTOR by Rapamycin suppressed high glucose-induced upregualtion of LC3 and P62 in HK2 cells. To evaluate the effects of mTOR inhibition, HK2 cells were exposed to high glucose (30 mM) with or without rapamycin (100 nm) for 48 hours. Western blot analysis showed that rapamycin inhibited high glucose-induced phosphorylation of mTOR (a) and p70S6 (c), expression of LC3 (e) and P62 (g) in HK2 cells. Quantification of expression of mTOR (b) and p70S6 (d), LC3 (f) and P62 (h) in HK2 cells. Results are presented as mean ± SEM. *P < 0.05 and **P < 0.01. N = 4.
Figure 8 Inhibition of mTOR by Rapamycin suppressed high glucose-induced upregualtion of LC3 and P62 in HK2 cells. To evaluate the effects of mTOR inhibition, HK2 cells were exposed to high glucose (30 mM) with or without rapamycin (100 nm) for 48 hours. Western blot analysis showed that rapamycin inhibited high glucose-induced phosphorylation of mTOR (a) and p70S6 (c), expression of LC3 (e) and P62 (g) in HK2 cells. Quantification of expression of mTOR (b) and p70S6 (d), LC3 (f) and P62 (h) in HK2 cells. Results are presented as mean ± SEM. *P < 0.05 and **P < 0.01. N = 4.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 136

Metadata

Authors
Huang, C., Zhang, Y., Kelly, D. J., Tan, C. Y. R., Gill, A., Cheng, D., Braet, F., Park, J.-S., Sue, C. M., Pollock, C. A., & Chen, X.-M.
Affiliations
  • The University of Sydney (AU)
  • The University of Melbourne (AU)
  • Royal North Shore Hospital (AU)
Corresponding author
Pollock, Carol A.
Venue
Scientific Reports
Published
2016-07-06
Volume
6
Issue
1
Pages
29196-29196
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2471394067
Cited by
136
References
30
Citations by year
2026: 8 · 2025: 14 · 2024: 11 · 2023: 23 · 2022: 18 · 2021: 22 · 2020: 14 · 2019: 14 · 2018: 4 · 2017: 7 · 2016: 1
FWCI
8.13
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • UNSWorks (UNSW Sydney) (submittedVersion, cc-by)
Funders
University of Sydney
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
Keywords
TXNIP, diabetic nephropathy, mitophagy, mTOR signaling, high glucose, mitochondrial reactive oxygen species, mitochondrial dysfunction, extracellular matrix deposition, renal fibrosis, BNIP3, proximal tubular epithelial cells, streptozotocin-induced diabetes
MeSH terms
Sequestosome-1 Protein, Animals, Autophagy, Carrier Proteins, Cell Line, Diabetic Nephropathies, Female, Glucose, Kidney Tubules, Membrane Proteins, Microtubule-Associated Proteins, Mitochondria, Signal Transduction, Up-Regulation, Cell Cycle Proteins, Sirolimus, Gene Silencing, Collagen Type I, Mitochondrial Proteins, Rats, TOR Serine-Threonine Kinases, Mitophagy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.